MBX Biosciences MBX 深 滬
等待開盤 01-03 09:30:00 美东时间
30.55
-0.990
-3.14%
華盛通- 最 高31.61
- 今 開31.60
- 成交量 56.41万股
- 最 低 29.63
- 昨 收 31.54
- 總市值 13.72亿
- 52周最高 35.55
- 市盈率 靜 --
- 換手率 1.26%
- 52周最低 4.8069
- 委 比 -76.07%
- 總股本 4490.23万
- 歷史最高 35.55
- 量 比 1.66
- 振 幅 6.28%
- 歷史最低 4.8069
- 每 手 1
- 風險率 6.96%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多美股大行评级 | 绩后评级出炉！联邦快递获多家大行上调目标价；耐克遭多家大行下调目标价
今日重点评级关注：HC Wainwright & Co.：维持Pyxis Oncology"买入"评级，目标价从5美元升至7美元；Stifel：维持Oculis Holding"买入"评级，目标价从35美元升至40美元
2025-12-22 15:05
Earnings Scheduled For December 18, 2025
Companies Reporting Before The Bell • Birkenstock Holding (NYSE:BIRK) is expect...
2025-12-18 19:11
MBX Biosciences to Present at the 44th Annual J.P. Morgan Healthcare Conference on January 13
MBX Biosciences, Inc. announced that its CEO, Kent Hawryluk, will present at the 44th Annual J.P. Morgan Healthcare Conference in San Francisco on January 13, 2026. The company, focused on developing precision peptide therapies for endocrine and metabolic disorders, will discuss its pipeline, including treatments for chronic hypoparathyroidism, obesity, and post-bariatric hypoglycemia. The event will be webcast and available for replay on the com...
2025-12-15 13:00
美股大行评级 | 潜在涨幅218.88%！Kyverna Therapeutics获摩根士丹利升目标价至25美元，维持"超配"评级
今日重点评级关注：摩根士丹利：维持Kyverna Therapeutics"超配"评级，目标价从20美元升至25美元；Maxim Group：维持Capricor Therapeutics"买入"评级，目标价从25美元升至50美元
2025-12-05 08:35
Goldman Sachs Initiates Coverage On MBX Biosciences with Sell Rating, Announces Price Target of $18
Goldman Sachs analyst Corinne Johnson initiates coverage on MBX Biosciences (NASDAQ:MBX) with a Sell rating and announces Price Target of $18.
2025-12-04 20:47
Catalyst Watch: Alibaba earnings, AI anxiety, airline M&A, and a Burry teaser
Welcome to Seeking Alpha's Catalyst Watch - a breakdown of some of next week's actionable events that stand out. Read more about the events that may impact stock prices next week. Monday - November ...
2025-11-22 04:00
MBX Biosciences to Participate in the 37th Annual Piper Sandler Healthcare Conference
MBX Biosciences announced that its President and CEO, Kent Hawryluk, and CMO, Sam Azoulay, will participate in the 37th Annual Piper Sandler Healthcare Conference on December 2-4 in New York. They will engage in fireside chats and 1x1 meetings during the event. The live webcast can be accessed via the Company’s website, and a replay will be available for 90 days. MBX Biosciences focuses on developing precision peptide therapies for endocrine and ...
2025-11-18 13:00
美股大行评级 | 花旗上调英伟达目标价从210美元升至220美元；DraftKings、DoubleVerify遭多家大行下调目标价
今日重点评级关注：Guggenheim：维持InflaRx"买入"评级，目标价从10美元升至22美元；巴克莱：维持Tandem糖尿病护理"超配"评级，目标价从51美元升至55美元
2025-11-11 10:49
MBX Biosciences Appoints Steven Hoerter as Executive Chair
MBX Biosciences, Inc. ( ($MBX) ) has shared an announcement. MBX Biosciences an...
2025-11-06 21:28
MBX Biosciences Q3 EPS $(0.63) Beats $(0.70) Estimate
MBX Biosciences (NASDAQ:MBX) reported quarterly losses of $(0.63) per share which beat the analyst consensus estimate of $(0.70) by 9.87 percent. This is a 77.34 percent increase over losses of $(2.78) per share from the
2025-11-06 21:14
